Join to View Full Profile
One Boston Medical Center PlBoston, MA 02118
Dr. McCarter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kaitlin McCarter is an internal medicine specialist located in Boston, MA, with subspecialties in hospital medicine and rheumatology. She completed her internal medicine residency at Boston University Medical Center in 2021 and is currently undergoing a rheumatology fellowship at Brigham and Women's Hospital. Dr. McCarter graduated from Sidney Kimmel Medical College in 2018 and holds a BA in Philosophy from Boston College. She works as a hospitalist at Brigham and Women's Hospital. Her research includes publications on rheumatoid arthritis and immune checkpoint inhibitors, with articles featured in Seminars in Arthritis and Rheumatism and The Lancet. Rheumatology.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Rheumatology, 2024 - 2026
Boston University Medical CenterResidency, Internal Medicine, 2018 - 2021
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2018
Boston CollegeBA, Philosophy, 2007 - 2011
Certifications & Licensure
MA State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study.Kathleen M M Vanni, Kaitlin R McCarter, Xiaosong Wang, Caitlyn Duffy, Jamie P Dela Cruz
The Lancet. Rheumatology. 2025-04-01 - 5 citationsImmunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for ca...Kaitlin R McCarter, Senada Arabelovic, Xiaosong Wang, Taylor Wolfgang, Kazuki Yoshida
Seminars in Arthritis and Rheumatism. 2024-02-01 - 14 citationsMortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospect...Kaitlin R McCarter, Taylor Wolfgang, Senada Arabelovic, Xiaosong Wang, Kazuki Yoshida
The Lancet. Rheumatology. 2023-05-01
Press Mentions
Cancer Drug Okay in Rheumatoid ArthritisApril 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
